Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:17:58.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy and safety evaluation of deucravacitinib versus placebo in participants with active psoriatic arthritis who are naïve to biologic disease-modifying anti-rheumatic drugs.
    Difference
    0.1%
    Check dated 2024-06-06T14:50:10.000Z thumbnail image
  7. Check
    13 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change likely indicates an update or revision in the estimated completion date for a study related to the efficacy and safety of Deucravacitinib in participants with active Psoriatic Arthritis who are naïve to biologic disease-modifying anti-rheumatic drugs.
    Difference
    0.0%
    Check dated 2024-06-03T13:59:38.000Z thumbnail image
  8. Check
    15 days ago
    Change Detected
    Summary
    The value on the webpage has changed from '22 C1430EGF 21 22' to '31 1430 Medellin, Colombia, 050021 Local Institution - 0094 29 (Estimated) 31'. This change likely represents an update related to a location in Medellin, Colombia, possibly indicating a new site or information regarding a local institution in the medical and healthcare field.
    Difference
    0.5%
    Check dated 2024-06-01T12:16:30.000Z thumbnail image
  9. Check
    23 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely indicates an update or modification in the estimated completion date for the study related to evaluating the efficacy and safety of Deucravacitinib in participants with active Psoriatic Arthritis who are naïve to biologic disease-modifying anti-rheumatic drugs.
    Difference
    0.0%
    Check dated 2024-05-24T04:13:56.000Z thumbnail image
  10. Check
    24 days ago
    Change Detected
    Summary
    The webpage now indicates that the study site at Arizona Arthritis and Rheumatology Associates is recruiting, with Joonhee Lim as the contact person. Additionally, the study site at Arthritis and Rheumatism Associates (ARA) in Jonesboro is also recruiting, with BEATA FILIP-MAJEWSKI as the contact person.
    Difference
    70%
    Check dated 2024-05-22T21:38:26.000Z thumbnail image

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.